CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.
about
Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature ReviewContinuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapyEarly development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitutionCancer biomarkers in HIV patientsDifferential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virusClinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.Immunotherapy for HIV-associated non-Hodgkin's lymphoma.An AIDS-defining neoplasm in a 30-year-old man on highly active antiretroviral therapy: a forgotten diagnosis?A review of the role of lymphoma markers and occupational and environmental exposures.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients.Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Remission of human immunodeficiency virus-related lymphoma in association with immune reconstitution on anti-retroviral therapy, without chemotherapy.PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvementIncidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.Extranodal lymphoma masquerading as carcinoma of the breast in an HIV-positive male patient.Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma.HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production.Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.HIV-related lymphoma
P2860
Q28081273-44F17E5B-1B5F-49DF-B3BD-F4B4B7D557AAQ33863292-C60C303B-1C21-4660-AFE5-177A5E0F23CEQ34498993-93AF66DB-896C-4B5C-A134-0CB9FC07A2C7Q34661370-8C8888D3-5DEC-415C-AC59-F84CD40EE266Q35112218-9B15D87D-21B8-466A-B1D0-416428C1BCD5Q35830555-94619E4E-CA58-4477-8BDC-03E44E969DCEQ36102589-639F1A40-79AF-4C55-A255-FBBF8F2F80A0Q37106782-63FC9888-876F-4981-BB78-51F862AFB6B2Q37567836-4AF071E8-FE74-4895-B8EE-017E53423929Q37684247-9B8FD89B-DF9B-40FC-BEC7-C255CB4BDF23Q38029093-AFB043E8-66DE-4541-8BA6-6302396806F8Q38210131-7FCF68EC-72C8-4EC8-992B-38A636AE311DQ38615024-6D0C1C54-4DD7-490C-A57B-1ECB196FE5F8Q40250347-85A6DAF0-0BC8-4935-89BC-B02058548B72Q40927354-B711CDD5-D603-4583-85ED-52C19B7E933AQ41101979-CCCCCA4E-8B6E-463D-947F-66E05FF08AE5Q41990454-05F6CA9C-CB24-465A-93E9-C74D077151EFQ42719779-E3434CCA-EF5A-439C-BD43-F4E5CCEC874BQ44314941-EF9370AF-976A-496C-B1B7-BDBCEFAEBE33Q45358998-39FA6C7B-B386-4E35-B54A-E13DE87AA658Q46245165-E041584F-1658-4F17-B046-E340EF8A42ECQ47266595-5949FA7B-B6A4-478F-B29D-3AF849C9CE4AQ50101286-A943F585-9854-4377-9B1D-841D705FB747Q56112360-399B13BB-65A5-489A-B00F-B070491879A8
P2860
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD4 counts and the risk of sys ...... ndividuals with HIV in the UK.
@en
CD4 counts and the risk of sys ...... ndividuals with HIV in the UK.
@nl
type
label
CD4 counts and the risk of sys ...... ndividuals with HIV in the UK.
@en
CD4 counts and the risk of sys ...... ndividuals with HIV in the UK.
@nl
prefLabel
CD4 counts and the risk of sys ...... ndividuals with HIV in the UK.
@en
CD4 counts and the risk of sys ...... ndividuals with HIV in the UK.
@nl
P2093
P2860
P50
P1433
P1476
CD4 counts and the risk of sys ...... ndividuals with HIV in the UK.
@en
P2093
Achim Schwenk
Andrew N Phillips
Brian Gazzard
Clifford Leen
Iain Reeves
John Walsh
Loveleen Bansi
Margaret Johnson
Mark Gompels
Martin Fisher
P2860
P304
P356
10.3324/HAEMATOL.2008.002691
P577
2009-03-31T00:00:00Z